Pharmaceutical Cleanroom News
Get the latest pharmaceutical cleanroom news and updates below. Cleanroom Connect brings you the latest news from around the world, featuring current topics and news in the Pharmaceutical and Biotech industries.
Researchers demonstrate first example of a bioresorbable electronic medicine Biodegradable implant provides electrical stimulation that speeds nerve regeneration Researchers at Northwestern University and Washington University School of Medicine in St. Louis have...
Lindström India launched its second line of business, called Cleanroom services in India to ensure the highest quality hygiene, safety and reliability which is most critical to customers in the pharmaceutical, food and electronics industry. Lindström’s cleanroom service ensures hygienic production facilities by providing garments serviced in cleanroom laundries which prevent contaminations during process hereby ensuring complete safety of the products being manufactured.
The Controlled Environmental Solutions business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.
A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility, and therefore is built in half the construction time with approximately one half of the operating cost of a traditional plant. The next-generation biomanufacturing plant require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.
The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma. The approval was based on a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania and was granted to Progenics Pharmaceuticals for AZEDRA.
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, announced it has moved into brand new lab space in Cambridge, MA. Located next to MIT, the newly renovated property puts Platelet BioGenesis in the heart of the most dynamic biotech cluster in the world.
The study demonstrates that the new plant system for norovirus vaccine production is effective against the tenacious pathogen and that the versatile method could be used for the development of a broad range of novel vaccines. It is estimated that an effective vaccine against gastroenteritis could save billions of dollars in healthcare costs in the U.S. alone.
Osteoarthritis (OA) is a joint disorder that affects 28 million people in the United States. With no current disease-modifying therapy for OA, most patients rely on symptomatic relief to manage joint inflammation and chronic pain.
When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as “construction workers” that clear away damaged tissue debris and initiate repair. However, prolonged inflammation promotes the progression of many diseases, including obesity.
With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a ‘state-of-the-art’ sterile dry powder injection cleanroom manufacturing facility for the production and packaging of sterile dry powder injection in Dubai. On approval of the new drug by US FDA, this manufacturing facility will be commissioned for commercial production.
Genomma Lab will be able to focus on lowering its production costs, and thus offering more affordable medicines and products across the region.”, said Mr Maximo Juda, CEO of the Company. “Both multi-lateral institutions will not only provide long-term financing but also key strategic advice given their extensive industry expertise in pharma and environmental matters”, added Mr. Antonio Zamora Galland, CFO of Genomma Lab
The Atropine Autoinjector initially received Emergency Use Authorization from the FDA in April 2017. Atropine is one of the most commonly used drugs for the treatment of chemical nerve agent poisoning. With the approved Atropine Autoinjector, U.S. troops can rapidly inject atropine into the thigh muscle following nerve agent exposure.
Pharmaceutical Cleanroom News and Advancements
The Pharmaceutical Cleanroom Industry or medicine industry is the commercial industry that discovers, develops, produces, and markets drugs or pharmaceuticals for various uses and formations of medicines and medications. The pharmaceutical cleanroom industry produces the controlled aseptic cleanroom environments where by the pharmaceutical products are created and packaged. Pharmaceutical companies create a various array of products for different applications.
The primary developments of Pharmaceutical companies are generic medications, branded pharmaceuticals and medical devices. The pharmaceutical companies are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. Cleanroom Connect provides the latest Pharmaceutical Cleanroom News from various pharmaceutical and biopharma industries. Subscribe today to receive pharmaceutical and biopharmaceutical news and updates directly to your mailbox.
The Pharmaceutical Cleanroom Industry is a booming industry, and production has been growing exponentially over the past few decades as innovations in the medical field have taken off. This increasing production has also led to increasing demands for safety features installed in industrial pharmaceutical manufacturing plants and storage areas. These safety procedures ensure the health of employees as well as the safe preservation of products that are stored for later use by consumers.